Inovio Pharmaceuticals, Inc ‘s INO shares rose over 10% after the company initiated a pivotal phase III REVEAL study to evaluate the safety and.

Inovio's HPV Immunotherapy Moves to Phase III, Stock Rises
Source: Virology News

Tagged with:
 

Comments are closed.